3.46 (-%)
As of Nov 20, 2024
Source:
Personalis, Inc strive to develop some of the most comprehensive and actionable cancer genomic tests in the world to help patients live better and longer lives. We believe we have one of the most discerning technologies to both characterize and monitor cancer – with the aim of driving a new paradigm for cancer management and guiding care from biopsy through the life of the patient.
Country | United States |
Headquarters | fremont, california |
Phone Number | 650-752-1300 |
Industry | services |
CEO | Christopher Hall |
Website | https://www.personalis.com |